Why Dosing and Side-Effect Management Should Not Be Casual GLP-1 medications usually require thoughtful titration, not a one-dose-fits-all approach
Mechanistically, SGLT2 inhibitors act predominantly through hemodynamic and cardiorenal pathways, whereas GLP-1 receptor agonists exert metabolic, anti-inflammatory, and anti-atherosclerotic effects, providing a rationale for potential complementarity
Plant-based ingredients (carrageenan), and alternative sweeteners for balanced wellness
That said, more studies need to be conducted before we draw any firm conclusions [12][13]
In 2025, I have been experimenting with a powerful triangle that is finally moving the needle: Wegovy, Vyvanse and Keto